
---
title: '手性金纳米颗粒可使疫苗效力提高25%以上'
categories: 
 - 新媒体
 - 科学网
 - 博客
headimg: 'https://cors.zfour.workers.dev/?http://image.sciencenet.cn/home/202204/21/092558hnc8u14gk01k7p2n.jpg'
author: 科学网
comments: false
date: Thu, 21 Apr 2022 09:30:00 GMT
thumbnail: 'https://cors.zfour.workers.dev/?http://image.sciencenet.cn/home/202204/21/092558hnc8u14gk01k7p2n.jpg'
---

<div>   
<p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-family: "times new roman"; font-size: 24px;">中</span></span><span style="font-family: "times new roman"; font-size: 24px;">巴</span><span style="font-family: "times new roman"; font-size: 24px;">美合作研究表明，手性金纳米颗粒可使疫苗效力提高</span><span style="font-family: "times new roman"; font-size: 24px;">25%</span><span style="font-family: "times new roman"; font-size: 24px;">以上</span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";">诸平</span></p><p style="text-align: center;"><a href="https://phys.org/news/2022-04-chiral-gold-nanoparticles-vaccine-efficacy.html" target="_self"><img src="https://cors.zfour.workers.dev/?http://image.sciencenet.cn/home/202204/21/092558hnc8u14gk01k7p2n.jpg" title alt="chiral-gold-nanopartic.jpg" referrerpolicy="no-referrer"></a><br></p><p style="line-height: 2em;"><span style="text-decoration: underline; font-size: 18px; font-family: "times new roman";"><a href="https://phys.org/news/2022-04-chiral-gold-nanoparticles-vaccine-efficacy.html" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank">Computational model of gold nanoparticle functionalized with left-handed enantiomers of cysteine and phenylalanine. Credit: André Farias de Moura</a></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";">据物理学家组织网（</span><a href="https://phys.org/news/2022-04-chiral-gold-nanoparticles-vaccine-efficacy.html" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Phys.Org</span></a><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">）</span>2022<span style="font-size: 18px; font-family: 宋体;">年</span>4<span style="font-size: 18px; font-family: 宋体;">月</span>18<span style="font-size: 18px; font-family: 宋体;">日报道，巴西研究人员参与的一项国际合作研究表明，通过添加左手性纳米金作为佐剂，疫苗的效力可以提高</span>25%<span style="font-size: 18px; font-family: 宋体;">以上（</span></span><a href="https://phys.org/news/2022-04-chiral-gold-nanoparticles-vaccine-efficacy.html" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Chiral gold nanoparticles increase vaccine efficacy by more than 25%, study suggests</span></a><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">）。相关研究结果于</span>2022<span style="font-size: 18px; font-family: 宋体;">年</span>1<span style="font-size: 18px; font-family: 宋体;">月</span>19<span style="font-size: 18px; font-family: 宋体;">日已经在《自然》（</span></span><a href="https://www.nature.com/articles/s41586-021-04243-2" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Nature</span></a><span style="font-size: 18px; font-family: "times new roman";">）杂志网站发表——</span><a href="https://www.nature.com/articles/s41586-021-04243-2#auth-Liguang-Xu" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Liguang Xu</span></a><span style="font-size: 18px; font-family: "times new roman";">, </span><a href="https://www.nature.com/articles/s41586-021-04243-2#auth-Xiuxiu-Wang" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Xiuxiu Wang</span></a><span style="font-size: 18px; font-family: "times new roman";">, </span><a href="https://www.nature.com/articles/s41586-021-04243-2#auth-Weiwei-Wang" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Weiwei Wang</span></a><span style="font-size: 18px; font-family: "times new roman";">, </span><a href="https://www.nature.com/articles/s41586-021-04243-2#auth-Maozhong-Sun" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Maozhong Sun</span></a><span style="font-size: 18px; font-family: "times new roman";">, </span><a href="https://www.nature.com/articles/s41586-021-04243-2#auth-Won_Jin-Choi" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Won Jin Choi</span></a><span style="font-size: 18px; font-family: "times new roman";">, </span><a href="https://www.nature.com/articles/s41586-021-04243-2#auth-Ji_Young-Kim" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Ji-Young Kim</span></a><span style="font-size: 18px; font-family: "times new roman";">, </span><a href="https://www.nature.com/articles/s41586-021-04243-2#auth-Changlong-Hao" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Changlong Hao</span></a><span style="font-size: 18px; font-family: "times new roman";">, </span><a href="https://www.nature.com/articles/s41586-021-04243-2#auth-Si-Li" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Si Li</span></a><span style="font-size: 18px; font-family: "times new roman";">, </span><a href="https://www.nature.com/articles/s41586-021-04243-2#auth-Aihua-Qu" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Aihua Qu</span></a><span style="font-size: 18px; font-family: "times new roman";">, </span><a href="https://www.nature.com/articles/s41586-021-04243-2#auth-Meiru-Lu" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Meiru Lu</span></a><span style="font-size: 18px; font-family: "times new roman";">, </span><a href="https://www.nature.com/articles/s41586-021-04243-2#auth-Xiaoling-Wu" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Xiaoling Wu</span></a><span style="font-size: 18px; font-family: "times new roman";">, </span><a href="https://www.nature.com/articles/s41586-021-04243-2#auth-Felippe_M_-Colombari" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Felippe M. Colombari</span></a><span style="font-size: 18px; font-family: "times new roman";">, </span><a href="https://www.nature.com/articles/s41586-021-04243-2#auth-Weverson_R_-Gomes" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Weverson R. Gomes</span></a><span style="font-size: 18px; font-family: "times new roman";">, </span><a href="https://www.nature.com/articles/s41586-021-04243-2#auth-Asdrubal_L_-Blanco" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Asdrubal L. Blanco</span></a><span style="font-size: 18px; font-family: "times new roman";">, </span><a href="https://www.nature.com/articles/s41586-021-04243-2#auth-Andre_F_-Moura" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Andre F. de Moura</span></a><span style="font-size: 18px; font-family: "times new roman";">, </span><a href="https://www.nature.com/articles/s41586-021-04243-2#auth-Xiao-Guo" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Xiao Guo</span></a><span style="font-size: 18px; font-family: "times new roman";">, </span><a href="https://www.nature.com/articles/s41586-021-04243-2#auth-Hua-Kuang" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Hua Kuang</span></a><span style="font-size: 18px; font-family: "times new roman";">, </span><a href="https://www.nature.com/articles/s41586-021-04243-2#auth-Nicholas_A_-Kotov" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Nicholas A. Kotov</span></a><span style="font-size: 18px; font-family: "times new roman";">, </span><a href="https://www.nature.com/articles/s41586-021-04243-2#auth-Chuanlai-Xu" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Chuanlai Xu</span></a><span style="font-size: 18px; font-family: "times new roman";">. Enantiomer-dependent immunological response to chiral nanoparticles. </span><a href="https://www.nature.com/" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Nature</span></a><span style="font-size: 18px; font-family: "times new roman";">, 2022, 601: 366–373. DOI: </span><a href="https://www.nature.com/articles/s41586-021-04243-2" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">10.1038/s41586-021-04243-2</span></a><span style="font-size: 18px; font-family: "times new roman";">.</span><a href="https://www.nature.com/articles/s41586-021-04243-2#article-info" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";"> Published: 19 January 2022</span></a><span style="font-size: 18px; font-family: "times new roman";">. </span><a href="https://www.nature.com/articles/s41586-021-04243-2" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">https://www.nature.com/articles/s41586-021-04243-2</span></a></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">有三个研究小组参与了这项研究，一个隶属于中国江南大学</span>(Jiangnan University, Wuxi, Jiangsu, China)<span style="font-size: 18px; font-family: 宋体;">，另一个隶属于美国密歇根大学</span>(University of Michigan, Ann Arbor, MI, USA)<span style="font-size: 18px; font-family: 宋体;">。巴西小组由安德鲁</span>·<span style="font-size: 18px; font-family: 宋体;">法瑞斯</span>·<span style="font-size: 18px; font-family: 宋体;">德莫拉（</span>Andr<span style="font-size: 18px; font-family: 宋体;">é</span> Farias de Moura<span style="font-size: 18px; font-family: 宋体;">）领导，他是圣卡洛斯联邦大学</span>(Federal University of São Carlos<span style="font-size: 18px; font-family: 宋体;">简称</span>UFSCar)<span style="font-size: 18px; font-family: 宋体;">化学系的教授，也是功能材料开发中心</span>(Center for Development of Functional Materials<span style="font-size: 18px; font-family: 宋体;">简称</span>CDMF)<span style="font-size: 18px; font-family: 宋体;">的研究员，该中心是圣保罗研究基金会（</span>FAPESP<span style="font-size: 18px; font-family: 宋体;">）资助的研究、创新和传播中心</span>(Research, Innovation and Dissemination Centers <span style="font-size: 18px; font-family: 宋体;">简称</span>RIDCs)<span style="font-size: 18px; font-family: 宋体;">之一。巴西小组除了来自</span>UFSCar<span style="font-size: 18px; font-family: 宋体;">的研究人员之外，还有来自巴西能源和材料研究中心（</span>Brazilian Center for Research in Energy and Materials, Campinas, São Paulo, Brazil<span style="font-size: 18px; font-family: 宋体;">）的研究人员。上述图片就是由安德鲁</span>·<span style="font-size: 18px; font-family: 宋体;">法瑞斯</span>·<span style="font-size: 18px; font-family: 宋体;">德莫拉提供的半胱氨酸（</span><a href="https://phys.org/news/2022-04-chiral-gold-nanoparticles-vaccine-efficacy.html" target="_self">cysteine</a><span style="font-size: 18px; font-family: 宋体;">）左手对映体和苯丙氨酸（</span><a href="https://phys.org/news/2022-04-chiral-gold-nanoparticles-vaccine-efficacy.html" target="_self">phenylalanine</a><span style="font-size: 18px; font-family: 宋体;">）左手对映体功能化金纳米颗粒的计算模型。</span></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">这项研究没有涉及</span>COVID-19<span style="font-size: 18px; font-family: 宋体;">疫苗，因为它早在大流行之前就开始了。研究人员使用了用于对抗特定流感病毒株的疫苗。虽然这不是目前在巴西流行的毒株，但原则上可以将结果推广到任何类型的疫苗，显然通过逐案补充研究。原因是左手性金纳米颗粒不是活性成分，而是增强受体免疫反应的佐剂。</span></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">安德鲁</span>·<span style="font-size: 18px; font-family: 宋体;">法瑞斯</span>·<span style="font-size: 18px; font-family: 宋体;">德莫拉告诉</span>FAPESP <span style="font-size: 18px; font-family: 宋体;">代理机构（</span>Ag<span style="font-size: 18px; font-family: 宋体;">ê</span>ncia FAPESP<span style="font-size: 18px; font-family: 宋体;">）</span>:<span style="font-size: 18px; font-family: 宋体;">“理解这些纳米颗粒贡献的关键是手性的概念，它适用于不能叠加在自己镜像上的物体或系统。”</span></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">手性（</span><a href="https://phys.org/news/2022-04-chiral-gold-nanoparticles-vaccine-efficacy.html" target="_self">Chirality</a><span style="font-size: 18px; font-family: 宋体;">）是一种不对称。这个词来源于古希腊语“</span>kheir<span style="font-size: 18px; font-family: 宋体;">”，相当于英文</span>hand<span style="font-size: 18px; font-family: 宋体;">（手）的意思，最好的例子就是左手和右手的区别。当我们对着镜子举起手时，我们在右边看到的手就是我们的左手，反之亦然。</span></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">“地球上的一切生物都是手性的。手性分子可以有完全不同的性质取决于它们是左手性还是右手性。同一分子的两种手性形式被称为对映体。”安德鲁</span>·<span style="font-size: 18px; font-family: 宋体;">法瑞斯</span>·<span style="font-size: 18px; font-family: 宋体;">德莫拉说，“一个悲剧性的例子是沙利度胺</span>(</span><a href="https://phys.org/news/2022-04-chiral-gold-nanoparticles-vaccine-efficacy.html" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">thalidomide</span></a><span style="font-size: 18px; font-family: "times new roman";">)<span style="font-size: 18px; font-family: 宋体;">，它是</span>20<span style="font-size: 18px; font-family: 宋体;">世纪</span>50<span style="font-size: 18px; font-family: 宋体;">年代末和</span>60<span style="font-size: 18px; font-family: 宋体;">年代为孕妇治疗妊娠反应晨吐而开的药物，但是，结果导致婴儿出生时出现一系列畸形。就是其中一种对映体具有预期的治疗效果，但另一种对映体使胎儿四肢萎缩，有致畸作用。”</span></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><strong><span style="font-size: 18px; font-family: 宋体;">纳米粒子（</span></strong><strong><span style="font-size: 18px; font-family: 宋体;"></span></strong><strong><a href="https://phys.org/news/2022-04-chiral-gold-nanoparticles-vaccine-efficacy.html" target="_blank">Nanoparticles</a></strong><strong><span style="font-size: 18px; font-family: 宋体;">）</span></strong></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">安德鲁</span>·<span style="font-size: 18px; font-family: 宋体;">法瑞斯</span>·<span style="font-size: 18px; font-family: 宋体;">德莫拉解释说，纳米材料的研究已经进步到足以让科学家完全分离一种对映体，而发表在《自然》杂志上的研究就是基于这种可能性。“我们从金纳米颗粒开始，它是对称的，缺乏手性，即它们是非手性的。我们首先通过让它们与氨基酸半胱氨酸相互作用来诱导它们的手性，然后将它们暴露在偏振光下，用氨基酸苯丙氨酸（</span></span><a href="https://phys.org/news/2022-04-chiral-gold-nanoparticles-vaccine-efficacy.html" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">amino acid phenylalanine</span></a><span style="font-size: 18px; font-family: "times new roman";">）作为光收集天线来加强诱导手性。”</span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">手性是用“</span><em>g</em><span style="font-size: 18px; font-family: 宋体;">因子（</span></span><a href="https://phys.org/news/2022-04-chiral-gold-nanoparticles-vaccine-efficacy.html" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><em><span style="font-size: 18px; font-family: "times new roman";">g</span></em><span style="font-size: 18px; font-family: "times new roman";">-factor</span></a><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">）”来衡量的，其值从</span>-2<span style="font-size: 18px; font-family: 宋体;">到</span>+2<span style="font-size: 18px; font-family: 宋体;">。这项研究中使用的程序使科学家能够超过</span>0.4<span style="font-size: 18px; font-family: 宋体;">，并产生了三种纳米颗粒</span>:<span style="font-size: 18px; font-family: 宋体;">原始的非手性金（</span></span><a href="https://phys.org/news/2022-04-chiral-gold-nanoparticles-vaccine-efficacy.html" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">achiral gold</span></a><span style="font-size: 18px; font-family: "times new roman";">）、右手性对映体（</span><a href="https://phys.org/news/2022-04-chiral-gold-nanoparticles-vaccine-efficacy.html" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">right-handed enantiomer</span></a><span style="font-size: 18px; font-family: "times new roman";">）和左手性对映体（</span><a href="https://phys.org/news/2022-04-chiral-gold-nanoparticles-vaccine-efficacy.html" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">left-handed enantiomer</span></a><span style="font-size: 18px; font-family: "times new roman";">）。</span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">“最初，我们在体外培养的人类免疫细胞上测试了纳米颗粒，发现手性纳米颗粒可以诱导产生与免疫反应相关的物质，即使在没有抗原的情况下，任何能够触发抗体产生的物质。这种反应正是佐剂在疫苗中的作用，”安德鲁</span>·<span style="font-size: 18px; font-family: 宋体;">法瑞斯</span>·<span style="font-size: 18px; font-family: 宋体;">德莫拉说。</span></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">接下来，研究人员在流感病毒上测试了纳米颗粒。安德鲁</span>·<span style="font-size: 18px; font-family: 宋体;">法瑞斯</span>·<span style="font-size: 18px; font-family: 宋体;">德莫拉说</span>:<span style="font-size: 18px; font-family: 宋体;">“我们发现对映体极大地增强了疫苗的效力。具体来说，与右手性对映体相比，左手性对映体的疗效提高了</span>25.8%<span style="font-size: 18px; font-family: 宋体;">，与非手性纳米颗粒相比，提高幅度更大。”</span></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">安德鲁</span>·<span style="font-size: 18px; font-family: 宋体;">法瑞斯</span>·<span style="font-size: 18px; font-family: 宋体;">德莫拉强调，任何想要使用这些知识的人都可以获得这些知识。“它可以被任何类型疫苗的任何生产商使用，包括</span>SARS-CoV-2<span style="font-size: 18px; font-family: 宋体;">的新变种疫苗或流感疫苗。虽然我们不是疫苗开发者，但我们将这种基础知识作为一个新的技术平台提供给那些开发者。”他说。</span></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";">上述介绍，仅供参考。欲了解更多信息，敬请注意浏览</span><a href="https://www.nature.com/articles/s41586-021-04243-2" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">原文</span></a><span style="font-size: 18px; font-family: "times new roman";">或者</span><a href="https://phys.org/news/2022-04-chiral-gold-nanoparticles-vaccine-efficacy.html" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">相关报道</span></a><span style="font-size: 18px; font-family: "times new roman";">。</span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";">使用手性金纳米粒子增强免疫反应（</span><a href="https://phys.org/news/2022-01-chiral-gold-nanoparticles-immune-response.html" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Using chiral gold nanoparticles to enhance immune response</span></a><span style="font-size: 18px; font-family: "times new roman";">）</span></p><p style="line-height: 2em;"><a href="https://www.nature.com/articles/s41586-021-04243-2" style="font-size: 18px; font-family: "arial black", "avant garde"; text-decoration: underline;" target="_blank"><span style="font-family: "arial black", "avant garde";">Abstract</span></a><br></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";">Chirality is a unifying structural metric of biological and abiological forms of matter. Over the past decade, considerable clarity has been achieved in understanding the chemistry and physics of chiral inorganic nanoparticles</span><a href="https://www.nature.com/articles/s41586-021-04243-2#ref-CR1" title="Ma, W. et al. Chiral inorganic nanostructures. Chem. Rev. 117, 8041–8093 (2017)." style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><sup><span style="font-size: 18px; font-family: "times new roman";">1</span></sup></a><sup><span style="font-size: 18px; font-family: "times new roman";">,</span></sup><a href="https://www.nature.com/articles/s41586-021-04243-2#ref-CR2" title="Copeland, L. O. & McDonald, M. B. in Principles of Seed Science and Technology 59–110 (Springer, 1999)." style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><sup><span style="font-size: 18px; font-family: "times new roman";">2</span></sup></a><sup><span style="font-size: 18px; font-family: "times new roman";">,</span></sup><a href="https://www.nature.com/articles/s41586-021-04243-2#ref-CR3" title="Zhang, Q. et al. Unraveling the origin of chirality from plasmonic nanoparticle-protein complexes. Science 365, 1475–1478 (2019)." style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><sup><span style="font-size: 18px; font-family: "times new roman";">3</span></sup></a><sup><span style="font-size: 18px; font-family: "times new roman";">,</span></sup><a href="https://www.nature.com/articles/s41586-021-04243-2#ref-CR4" title="Guerrero-Martínez, A., Alonso-Gómez, J. L., Auguié, B., Cid, M. M. & Liz-Marzán, L. M. From individual to collective chirality in metal nanoparticles. Nano Today 6, 381–400 (2011)." style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><sup><span style="font-size: 18px; font-family: "times new roman";">4</span></sup></a><span style="font-size: 18px; font-family: "times new roman";">; however, little is known about their effects on complex biochemical networks</span><a href="https://www.nature.com/articles/s41586-021-04243-2#ref-CR5" title="Kuznetsova, V. A. et al. Enantioselective cytotoxicity of ZnS:Mn quantum dots in A549 cells. Chirality 29, 403–408 (2017)." style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><sup><span style="font-size: 18px; font-family: "times new roman";">5</span></sup></a><sup><span style="font-size: 18px; font-family: "times new roman";">,</span></sup><a href="https://www.nature.com/articles/s41586-021-04243-2#ref-CR6" title="Sun, M. et al. Site-selective photoinduced cleavage and profiling of DNA by chiral semiconductor nanoparticles. Nat. Chem. 10, 821–830 (2018)." style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><sup><span style="font-size: 18px; font-family: "times new roman";">6</span></sup></a><span style="font-size: 18px; font-family: "times new roman";">. Intermolecular interactions of biological molecules and inorganic nanoparticles show some commonalities</span><a href="https://www.nature.com/articles/s41586-021-04243-2#ref-CR7" title="Kotov, N. A. Inorganic nanoparticles as protein mimics. Science 330, 188–189 (2010)." style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><sup><span style="font-size: 18px; font-family: "times new roman";">7</span></sup></a><sup><span style="font-size: 18px; font-family: "times new roman";">,</span></sup><a href="https://www.nature.com/articles/s41586-021-04243-2#ref-CR8" title="Cagno, V. et al. Broad-spectrum non-toxic antiviral nanoparticles with a virucidal inhibition mechanism. Nat. Mater. 17, 195–203 (2018)." style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><sup><span style="font-size: 18px; font-family: "times new roman";">8</span></sup></a><sup><span style="font-size: 18px; font-family: "times new roman";">,</span></sup><a href="https://www.nature.com/articles/s41586-021-04243-2#ref-CR9" title="Wang, D. et al. Engineering nanoparticles to locally activate T cells in the tumor microenvironment. Sci. Immunol. 4, eaau6584 (2019)." style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><sup><span style="font-size: 18px; font-family: "times new roman";">9</span></sup></a><span style="font-size: 18px; font-family: "times new roman";">, but these structures differ in scale, in geometry and in the dynamics of chiral shapes, which can both impede and strengthen their mirror-asymmetric complexes. Here we show that achiral and left- and right-handed gold biomimetic nanoparticles show different in vitro and in vivo immune responses. We use irradiation with circularly polarized light (CPL) to synthesize nanoparticles with controllable nanometre-scale chirality and optical anisotropy factors (<em>g</em>-factors) of up to 0.4. We find that binding of nanoparticles to two proteins from the family of adhesion G-protein-coupled receptors (AGPCRs)—namely cluster-of-differentiation 97 (CD97) and epidermal-growth-factor-like-module receptor 1 (EMR1)—results in the opening of mechanosensitive potassium-efflux channels, the production of immune signalling complexes known as inflammasomes, and the maturation of mouse bone-marrow-derived dendritic cells. Both in vivo and in vitro immune responses depend monotonically on the g-factors of the nanoparticles, indicating that nanoscale chirality can be used to regulate the maturation of immune cells. Finally, left-handed nanoparticles show substantially higher (1258-fold) efficiency compared with their right-handed counterparts as adjuvants for vaccination against the H9N2 influenza virus, opening a path to the use of nanoscale chirality in immunology.</span></p>                    <br><br>
                                        <label style="font-size:13px; color:#850f0f">转载本文请联系原作者获取授权，同时请注明本文来自诸平科学网博客。<br>链接地址：</label><a href="https://blog.sciencenet.cn/blog-212210-1334919.html" target="_blank" style="font-size:13px; color:#850f0f">https://blog.sciencenet.cn/blog-212210-1334919.html </a>
  <br><br>上一篇：<a href="http://blog.sciencenet.cn/blog-212210-1334771.html" target="_black">克服 COVID 变种：诱饵纳米粒子在冠状病毒进化过程中欺骗它</a><br>                    <!--大赛结束-->
                                        
  
</div>
            